Plus investor roadshows in Boston, NY, SF, LA
CEO, commented, "The recognition of the potential of our technology by a foremost public health authority in the United States, is a significant milestone in our clinical development program."
Inveestors should be stepping in now prior to the runup for the start of this phase 2 collaboration. Expected prior to end of 2015.
under Media tab
July 11 2015 interview at the 4 minute mark, the reporter states the company market cap is 14-15 Million. I am going to assume she means USD. Stock closed at 4.12 the day before the interview July 10.
$NVAX could buy Biondvax for $100 pps and that would be undervalued
Sentiment: Strong Buy
sal is very smart to buy shares without moving the stock price... he must be very experienced
why is there one poster who continues to be negative while holding an undwerwater position ?
ignore the psycho
are you bidding for shares sal? :)